Hemogenyx Pharma (HEMO.L): Approval of Hu-PHEC cell therapy patent | e-therapeutics (ETX.L): Board restructuring

11 Feb 2020
SP Angel Healthcare Conditions

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
SP Angel Healthcare Conditions
- Published:
11 Feb 2020 -
Author:
Vadim Alexandre | Liam Gascoigne-Cohen -
Pages:
3 -
Hemogenyx Pharma (HEMO.L): Approval of Hu-PHEC cell therapy patent | e-therapeutics (ETX.L): Board restructuring